鞘氨醇-1-磷酸通过激活大鼠小静脉内皮鞘氨醇-1-磷酸受体 1 预防通透性增加。

Sphingosine-1-phosphate prevents permeability increases via activation of endothelial sphingosine-1-phosphate receptor 1 in rat venules.

机构信息

Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, West Virginia 26506-9229, USA.

出版信息

Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1494-504. doi: 10.1152/ajpheart.00462.2010. Epub 2010 Aug 20.

Abstract

Sphingosine-1-phosphate (S1P) has been demonstrated to enhance endothelial barrier function in vivo and in vitro. However, different S1P receptor subtypes have been indicated to play different or even opposing roles in the regulation of vascular barrier function. This study aims to differentiate the roles of endogenous endothelial S1P subtype receptors in the regulation of permeability in intact microvessels using specific receptor agonist and antagonists. Microvessel permeability was measured with hydraulic conductivity (L(p)) in individually perfused rat mesenteric venules. S1P-mediated changes in endothelial intracellular Ca(2+) concentration (Ca(2+)) was measured in fura-2-loaded venules. Confocal images of fluorescent immunostaining illustrated the spatial expressions of three S1P subtype receptors (S1P(R1-3)) in rat venules. The application of S1P (1 μM) in the presence of S1P(R1-3) inhibited platelet-activating factor- or bradykinin-induced permeability increase. This S1P effect was reversed only with a selective S1P(R1) antagonist, W-146, and was not affected by S1P(R2) or S1P(R3) antagonists JTE-013 and CAY-10444, respectively. S1P(R1) was also identified as the sole receptor responsible for S1P-mediated increases in endothelial Ca(2+). S1P(R2) or S1P(R3) antagonist alone affected neither basal L(p) nor platelet-activating factor-induced permeability increase. The selective S1P(R1) agonist, SEW-2871, showed similar Ca(2+) and permeability effect to that of S1P. These results indicate that, despite the presence of S1P(R1-3) in the intact venules, only the activation of endothelial S1P(R1) is responsible for the protective action of S1P on microvessel permeability and that endogenous S1P(R2) or S1P(R3) did not exhibit functional roles in the regulation of permeability under basal or acutely stimulated conditions.

摘要

鞘氨醇-1-磷酸(S1P)已被证明可在体内和体外增强内皮屏障功能。然而,不同的 S1P 受体亚型在调节血管屏障功能方面发挥不同甚至相反的作用。本研究旨在使用特定的受体激动剂和拮抗剂区分内源性内皮 S1P 亚型受体在完整微血管通透性调节中的作用。通过单独灌注的大鼠肠系膜小静脉水力传导率(L(p))测量微血管通透性。用负载 fura-2 的小静脉测量 S1P 介导的内皮细胞内 Ca(2+)浓度 (Ca(2+))变化。共聚焦图像荧光免疫染色显示了大鼠小静脉中三种 S1P 亚型受体(S1P(R1-3))的空间表达。在 S1P(R1-3)存在的情况下应用 S1P(1 μM)可抑制血小板激活因子或缓激肽诱导的通透性增加。这种 S1P 作用仅被选择性 S1P(R1)拮抗剂 W-146 逆转,而不受 S1P(R2)或 S1P(R3)拮抗剂 JTE-013 和 CAY-10444 的影响。S1P(R1)也被确定为唯一负责 S1P 介导的内皮细胞 Ca(2+)增加的受体。单独的 S1P(R2)或 S1P(R3)拮抗剂既不影响基础 L(p),也不影响血小板激活因子诱导的通透性增加。选择性 S1P(R1)激动剂 SEW-2871 显示出与 S1P 相似的 Ca(2+)和通透性作用。这些结果表明,尽管完整的小静脉中存在 S1P(R1-3),但只有内皮 S1P(R1)的激活才负责 S1P 对微血管通透性的保护作用,而内源性 S1P(R2)或 S1P(R3)在基础或急性刺激条件下调节通透性时没有发挥功能作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索